Product Details-
| Composition | Quetiapine Fumarate 25mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 10×10 |
| Packing | Blister |
Qutaviv 25 is a premium formulation containing Quetiapine Fumarate 25 mg, designed to provide reliable, clinically tested support in the treatment of schizophrenia, bipolar disorder, and certain types of depression. Known for its balanced efficacy and tolerability, Qutaviv 25 helps restore mental stability, improve mood, and enhance the quality of life for patients struggling with psychiatric conditions. With the right medical supervision, Qutaviv 25 can become an essential part of a long-term recovery and stability plan.
Mental health disorders can deeply affect a person’s daily life, emotional balance, and relationships. Schizophrenia, bipolar disorder, and major depressive episodes are serious conditions that require precise treatment plans. Qutaviv 25 plays a significant role in such plans by helping control symptoms like hallucinations, mood swings, depressive thoughts, and extreme emotional highs or lows. A consistent and properly guided use of Qutaviv 25 can bring about a noticeable transformation in a patient’s mental health journey.
Qutaviv 25 contains Quetiapine Fumarate 25 mg as its active pharmaceutical ingredient. This atypical antipsychotic works by modulating the activity of certain neurotransmitters in the brain, particularly dopamine and serotonin, which are responsible for regulating mood, perception, and cognitive function.
Standardized 25 mg dose for flexible treatment planning.
Manufactured under strict quality controls for maximum purity and efficacy.
Clinically validated for use in multiple psychiatric conditions.
Qutaviv 25 acts primarily as an antagonist to dopamine D2 and serotonin 5-HT2A receptors. By balancing these neurotransmitter levels, it helps normalize thought processes, reduce hallucinations, and stabilize mood fluctuations. This dual action makes Qutaviv 25 effective in both psychotic disorders and mood-related conditions.
Reduces positive symptoms of schizophrenia such as delusions and hallucinations.
Helps control negative symptoms like lack of motivation and social withdrawal.
Stabilizes manic and depressive episodes in bipolar disorder.
Supports cognitive clarity and focus.
Qutaviv 25 is indicated for:
Schizophrenia: Managing both positive and negative symptoms.
Bipolar Disorder: Treating manic and depressive episodes, and maintaining mood stability.
Major Depressive Disorder (Adjunctive Use): Enhancing the effectiveness of antidepressants in resistant cases.
Generalized Anxiety in Psychiatric Contexts: Where approved by a healthcare provider.
The exact dosage of Qutaviv 25 should be determined by a psychiatrist or healthcare professional based on the patient’s age, condition severity, and treatment response.
Initial Dose: Often started at 25 mg once or twice daily.
Titration: Gradually increased based on tolerance and therapeutic effect.
Administration: Can be taken with or without food, ideally at the same time each day to maintain stable blood levels.
Psychiatric treatments often require a long-term approach. Qutaviv 25 may be prescribed for weeks, months, or even years, depending on the patient’s condition and risk of relapse. Abrupt discontinuation should be avoided to prevent withdrawal symptoms and symptom rebound.
Symptom Relief: Reduces psychotic and mood disorder symptoms effectively.
Quality of Life Improvement: Enables better social interaction, work productivity, and emotional stability.
Proven Tolerability: Lower risk of certain side effects compared to older antipsychotics.
Flexible Dosing: Allows gradual titration to the optimal dose.
While generally well-tolerated, some patients may experience:
Drowsiness or sedation
Dry mouth
Constipation
Weight gain
Mild dizziness
Orthostatic hypotension
Extrapyramidal symptoms (rigidity, tremors)
Neuroleptic malignant syndrome
Changes in cholesterol or blood sugar
Patients are advised to report unusual or severe symptoms to their doctor immediately.
Medical History: Inform your doctor of any cardiovascular conditions, liver problems, or history of seizures.
Pregnancy & Lactation: Use only if the potential benefits outweigh the risks.
Alcohol: Avoid alcohol as it may intensify drowsiness and other side effects.
Driving & Machinery: Caution is advised until you know how Qutaviv 25 affects you.
Qutaviv 25 may interact with:
Other antipsychotics
Antidepressants
Antifungal medications
Certain antibiotics
Anti-epileptic drugs
A complete list of current medications should be shared with the prescribing physician to avoid harmful interactions.
Store at room temperature away from moisture and sunlight.
Keep out of reach of children and pets.
Use before the expiry date for maximum effectiveness.
Take Qutaviv 25 exactly as prescribed.
Do not skip doses, and avoid sudden discontinuation.
Maintain regular follow-ups with your healthcare provider.
Combine medication with therapy, lifestyle adjustments, and social support for the best results.
Qutaviv 25 stands out for its high manufacturing standards, clinical effectiveness, and patient-friendly tolerability profile. By targeting both mood and psychotic symptoms, it provides a comprehensive solution for individuals seeking stability and recovery from complex psychiatric conditions.
With consistent use and proper medical guidance, Qutaviv 25 can help patients achieve long-term stability, reduce the risk of relapse, and live fulfilling lives despite the challenges of psychiatric disorders.
Qutaviv 25 is more than just a medication; it is a stepping stone toward a balanced, stable, and healthier mind. Backed by medical science and trusted by mental health professionals, Qutaviv 25 offers hope and healing to those in need. Always consult your healthcare provider before starting or adjusting your treatment with Qutaviv 25.
